Bath & Body Works (NYSE:BBWI) Price Target Raised to $39.00 at Piper Sandler

Bath & Body Works (NYSE:BBWI) had its price objective boosted by equities research analysts at Piper Sandler from $36.00 to $39.00 in a research report issued on Monday,Benzinga reports. The brokerage presently has a “neutral” rating on the stock. Piper Sandler’s target price points to a potential upside of 6.04% from the stock’s current price.

Several other brokerages also recently issued reports on BBWI. Deutsche Bank Aktiengesellschaft raised their price target on Bath & Body Works from $51.00 to $52.00 and gave the stock a “buy” rating in a report on Tuesday, November 26th. Telsey Advisory Group reiterated an “outperform” rating and issued a $42.00 target price on shares of Bath & Body Works in a research note on Monday, November 25th. Barclays upped their price target on shares of Bath & Body Works from $28.00 to $34.00 and gave the stock an “underweight” rating in a research report on Tuesday, November 26th. Morgan Stanley reduced their target price on shares of Bath & Body Works from $51.00 to $48.00 and set an “overweight” rating for the company in a research note on Thursday, November 21st. Finally, Wells Fargo & Company raised their price target on shares of Bath & Body Works from $38.00 to $42.00 and gave the company an “equal weight” rating in a research note on Thursday, December 12th. One research analyst has rated the stock with a sell rating, six have given a hold rating and nine have assigned a buy rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $42.69.

Bath & Body Works Price Performance

Bath & Body Works stock opened at $36.78 on Monday. Bath & Body Works has a 12 month low of $26.20 and a 12 month high of $52.99. The company has a fifty day moving average price of $35.27 and a two-hundred day moving average price of $33.76. The company has a market cap of $7.97 billion, a PE ratio of 8.97, a P/E/G ratio of 1.43 and a beta of 1.82.

Bath & Body Works (NYSE:BBWI) last posted its quarterly earnings results on Monday, November 25th. The company reported $0.49 EPS for the quarter, beating the consensus estimate of $0.46 by $0.03. The business had revenue of $1.61 billion during the quarter, compared to analyst estimates of $1.58 billion. Bath & Body Works had a net margin of 12.43% and a negative return on equity of 44.03%. The company’s quarterly revenue was up 3.1% on a year-over-year basis. During the same period in the previous year, the business posted $0.48 EPS. Equities research analysts anticipate that Bath & Body Works will post 3.26 earnings per share for the current year.

Institutional Trading of Bath & Body Works

Several institutional investors have recently modified their holdings of BBWI. Lone Pine Capital LLC grew its holdings in Bath & Body Works by 15.8% during the second quarter. Lone Pine Capital LLC now owns 11,315,515 shares of the company’s stock worth $441,871,000 after acquiring an additional 1,547,399 shares during the period. Anomaly Capital Management LP bought a new position in shares of Bath & Body Works during the 2nd quarter valued at about $113,995,000. FMR LLC grew its stake in shares of Bath & Body Works by 17,496.5% in the 3rd quarter. FMR LLC now owns 2,516,127 shares of the company’s stock worth $80,315,000 after purchasing an additional 2,501,828 shares during the last quarter. Sound Shore Management Inc. CT raised its holdings in shares of Bath & Body Works by 10.0% in the 2nd quarter. Sound Shore Management Inc. CT now owns 2,088,703 shares of the company’s stock worth $81,564,000 after purchasing an additional 189,889 shares in the last quarter. Finally, KBC Group NV lifted its stake in Bath & Body Works by 9,023.5% during the third quarter. KBC Group NV now owns 1,701,813 shares of the company’s stock valued at $54,322,000 after purchasing an additional 1,683,160 shares during the last quarter. Institutional investors and hedge funds own 95.14% of the company’s stock.

Bath & Body Works Company Profile

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.